Pawel Muranski, MD specializes in bone marrow transplant (BMT). He is the Assistant Professor of Medicine, Division of Hematology/Oncology at Columbia University Medical Center where he heads Columbia Cellular Immunotherapy Laboratory (CITL). He is a principal investigator at the Columbia Center for Translational Immunology and a member of the Herbert Irving Comprehensive Cancer Center. He trained at Hematology Branch, NHLBI/NIH and at the Surgery Branch, National Cancer Institute, NIH. His laboratory focuses on the basic and translational aspects of CD4+ T cell biology in the context of tumor immunology and immunotherapy. He is also interested in preclinical development and clinical use of novel cellular therapies targeting tumor and viral antigens including polyomaviruses (BK, JC and Merkel Cell Polyomavirus) aimed at prevention and treatment of viral infections in transplant recipients and other immunocompromised patients. In collaboration with Dr. Cortese (NINDS/NIH) he has developed a study of adoptive immunotherapy for patients with JC virus-associated Progressive Multifocal Leukoencephalopathy (PML).